2024 MIPS Measures Relevant to Radiologists

  1. Quality - 30% of total score:  Choose 6 measures, including one Outcome or other High Priority measure, and include 100% of denominator eligible encounters (entire year, all insurances). Report (provide answers for) at least 75% to receive a score based on 2024 National Benchmarks.

     

    ID:
    145
    NQF:
    eMeasure ID:
    High Priority:
    Yes

    2024 MIPS Measure #145: Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy

    Final reports for procedures using fluoroscopy that document radiation exposure indices.

    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    • Interventional Radiology
    Read more
    ID:
    360
    NQF:
    eMeasure ID:
    High Priority:
    Yes

    2024 MIPS Measure #360: Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies

    Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that the patient has received in the 12-month period prior to the current study.

    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    Read more
    ID:
    364
    NQF:
    eMeasure ID:
    High Priority:
    Yes

    2024 MIPS Measure #364: Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines

    Percentage of final reports for CT imaging studies with a finding of an incidental pulmonary nodule for patients aged 35 years and older that contain an impression or conclusion that includes a recommended interval and modality for follow-up (e.g., type of imaging or biopsy) or for no follow-up, and source of recommendations (e.g., guidelines such as Fleischner Society, American Lung Association, American College of Chest Physicians).

    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    Read more
    ID:
    405
    NQF:
    eMeasure ID:
    High Priority:
    Yes

    2024 MIPS Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions

    Percentage of final reports for imaging studies for patients aged 18 years and older with one or more of the following noted incidentally with a specific recommendation for no follow‐up imaging recommended based on radiological findings:

    • Cystic renal lesion that is simple appearing* (Bosniak I or II)
    • Adrenal lesion less than or equal to 1.0 cm
    • Adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign or diagnostic benign by unenhanced CT or washout protocol CT, or MRI with in- and opposed-phase sequences or other equivalent institutional imaging protocols
    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    Read more
    ID:
    406
    NQF:
    eMeasure ID:
    High Priority:
    Yes

    2024 MIPS Measure #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients

    Percentage of final reports for computed tomography (CT), CT angiography (CTA) or magnetic resonance imaging (MRI) or magnetic resonance angiogram (MRA) studies of the chest or neck for patients aged 18 years and older with no known thyroid disease with a thyroid nodule < 1.0 cm noted incidentally with follow-up imaging recommended.

    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    Read more
    ID:
    436
    NQF:
    eMeasure ID:
    High Priority:
    No

    2024 MIPS Measure #436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques

    Percentage of final reports for patients aged 18 years and older undergoing computed tomography (CT) with documentation that one or more of the following dose reduction techniques were used.

    • Automated exposure control
    • Adjustment of the mA and/or kV according to patient size
    • Use of iterative reconstruction technique
    Measure Type
    • Process
    Specifications
    Registry
    Specialty
    • Diagnostic Radiology
    Read more
  2. PI: Promoting Interoperability - 25% of total score: For a minimum of 180 days, report all required measures. EHR technology certified to the 2015 Cures Update must be in place by July 4, 2024. There are exclusions available for most of the required measures. Please check your QPP Participation Status to see if you are automatically exempt from PI. If you are exempt, the 25% will be re-weighted to the Quality performance category making it 55% of your score.
  3. IA: Improvement Activities - 15% of total score: Attest that you completed up to 2 high-weighted activities or 4 medium-weighted activities for a minimum of 90 days. Groups with 15 or fewer participants or if you are in a rural or health professional shortage area: Attest that you completed 1 high-weighted or 2 medium-weighted activities for a minimum of 90 days. A group can attest to an activity when at least 50% of the clinicians in the group perform the same activity during any continuous 90-day period (or as specified in the activity description) in the same performance year. Suggestions that might be applicable to your specialty include:

Register with MDinteractive